Cantourage says HIGH!


About Cantourage

Cantourage is a publicly listed, leading European medical cannabis company. The Berlin-based company with subsidiaries in the United Kingdom and Poland, was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol. The company was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under the stock ticker “HIGH”.

Stock chart

Basic information

First trading day  

11/11/2022

Securities identification number   

A3DSV0

ISIN

DE000A3DSV01

LEI

3912003NCTLO6YHA9V48

Ticker Symbol   

HIGH

Segment

Scale

Market

Open Market

Trading venues   

XETRA, Frankfurt (Scale), Open Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange

Class of shares

Bearer shares

Share capital in EUR

12,467,479.00

Number of shares  

12,467,479

Designated Sponsor

Hauck Aufhäuser/mwb fairtrade Wertpapierhandelsbank, both Frankfurt am Main

Specialist

WOLFGANG STEUBING AG

Paying agent

Hauck Aufhäuser Lampe Privatbank AG, Kaiserstrasse 24, 60311 Frankfurt am Main

Financial year   

1 January to 31 December

Press releases

Cantourage in the media